This report includes an assessment of the performance of the state and territory on the basis of the performance criteria set out in the National Partnership for Vital Vaccines (NPEV) for the second year of the agreement for the evaluation period from April 1, 2018 to March 31, 2019. The remaining scale, an increase in the vaccination rate of young boys and girls for human papillomavirus compared to the baseline, was not assessed during this period due to the ongoing transition of HPV registry data to the Australian immunization registry. This benchmark will be assessed initially in the second year of the agreement. The NPEV is an agreement between the Commonwealth of Australia and the States and Territories that aims to “protect the Australian public from the spread of vaccine-preventable diseases by implementing low-cost and effective immunization programs under the national immunization programme.” 1 Areas with low vaccine protection are indicated as areas where coverage rates are 5% or less than the national average and with at least 2% of the population for the age group concerned (see Appendix A). 5. an annual reduction in the rate of waste and leakage of agreed vaccines relative to the baseline. The performance criteria assessed in this report are: the objective of the benchmark is to improve coverage in areas with low coverage, so that the result of low area coverage indicates that the intent has been met. This approach is different from previous reporting cycles, where an independent review of low-coverage areas was not available within the time frame required for reporting (this did not affect countries` merits in premium payments). 4. an increase in vaccination rates for people aged 60 to <63 months in four of the ten lowest SA3 zones relative to the base the reference specifications 2 does not provide information on the assessment of jurisdictions without areas of low coverage. On the basis of the 2014-15 reporting cycle, the Productivity Commission has adopted the approach that a jurisdiction that does not have limited coverage for both age groups (and for which this has been independently reviewed by the Commonwealth Department of Health) is considered to meet the benchmark. 2.
Increased vaccination rates for Aboriginal and Torres Strait Islanders in at least two of the following three age cohorts: 12-<15 months; 24-<27 months; 60-<63 months, in terms of baseline rates, increased in almost all low-coverage target areas.